DO SPECIALTY DRUGS OFFER LARGER POPULATION HEALTH BENEFITS THAN NON-SPECIALTY DRUGS?
نویسندگان
چکیده
منابع مشابه
The value of specialty oncology drugs.
OBJECTIVE To estimate patients' elasticity of demand, willingness to pay, and consumer surplus for five high-cost specialty medications treating metastatic disease or hematologic malignancies. DATA SOURCE/STUDY SETTING Claims data from 71 private health plans from 1997 to 2005. STUDY DESIGN This is a revealed preference analysis of the demand for specialty drugs among cancer patients. We ex...
متن کاملHealth plan utilization and costs of specialty drugs within 4 chronic conditions.
BACKGROUND Drugs are most typically defined as specialty because they are expensive; however, other criteria used to define a drug as specialty include biologic drugs, the need to inject or infuse the drug, the requirement for special handling, or drug availability only via a limited distribution network. Specialty drugs play an increasingly important role in the treatment of chronic conditions...
متن کاملThe redesign of consumer cost sharing for specialty drugs at the California Health Insurance Exchange.
This paper describes the redesign of health benefits at Covered California-the nation's largest health insurance exchange, which covers 1.3 million individuals, and its benefit designs extending to hundreds of thousands more enrollees through insurance products sold outside the exchange-with respect to specialty drugs for the 2016 enrollment year. The catalyst for benefit redesign came from adv...
متن کاملProbing Our Moral Values in Health Care: The Pricing of Specialty Drugs.
JAMA: The US House Committee on Appropriations has approved a draft 2016 budget forHealth andHumanServices that would terminate funding for AHRQ. That happened in 2012 and AHRQ survived. What’s your take onhowyou’re in the same place again, andwhatdoyou seeas theway forward? DRKRONICK: My job as director is to try to explainasclearlyas I can theworkwedoand the value of that work. The appropriat...
متن کاملP 59: Non-Steroidal Anti-Inflammatory Drugs as a Prevention of Alzheimer Disease: Risks and Benefits
Alzheimer's disease (AD) is a chronic neurodegenerative disease that accounts for 60 to 80 percent of all dementia cases. The exact cause of Alzheimer`s disease is still unknown, but recent studies suggest neuro-inflammation as an important part of the pathogenesis of the disease. This brings in mind using non-steroidal anti-inflammatory drugs (NSAID) as treatment or prevention of the disease. ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2016
ISSN: 1098-3015
DOI: 10.1016/j.jval.2016.03.1936